Schnurri-2 Controls BMP-Dependent Adipogenesis via Interaction with Smad Proteins  by Jin, Wanzhu et al.
Developmental Cell 10, 461–471, April, 2006 ª2006 Elsevier Inc. DOI 10.1016/j.devcel.2006.02.016Schnurri-2 Controls BMP-Dependent Adipogenesis
via Interaction with Smad ProteinsWanzhu Jin,1 Tsuyoshi Takagi,1
Shin-nosuke Kanesashi,1 Toshihiro Kurahashi,1,2
Teruaki Nomura,1,2 Jun Harada,1
and Shunsuke Ishii1,2,3,*










Adipocytedifferentiation is an important componentof
obesity, but howhormonal cuesmediate adipocyte dif-
ferentiation remains elusive. BMP stimulates in vitro
adipocyte differentiation, but the role of BMP in adipo-
genesis in vivo is unknown. Drosophila Schnurri (Shn)
is required for the signaling of Decapentaplegic, a
Drosophila BMP homolog, via interaction with the
Mad/Medea transcription factors. Vertebrates have
three Shn orthologs, Shn-1, -2, and -3. Here, we report
that Shn-22/2mice have reduced white adipose tissue
and that Shn-22/2 mouse embryonic fibroblasts can-
not efficiently differentiate into adipocytes in vitro.
Shn-2 enters the nucleus upon BMP-2 stimulation
and, in cooperationwithSmad1/4andC/EBPa, induces
the expression of PPARg2, a key transcription factor
for adipocyte differentiation. Shn-2 directly interacts
with both Smad1/4 and C/EBPa on the PPARg2
promoter. These results indicate that Shn-2-mediated
BMP signaling has a critical role in adipogenesis.
Introduction
White adipose tissue plays an important role in energy
balance through its ability to store triacylglycerol and re-
lease free fatty acids and glycerol. The mechanism of
adipocyte differentiation has been extensively studied
using preadipocyte cell lines (Rosen et al., 2000). Upon
reaching confluence, proliferating preadipocytes be-
come growth arrested by contact inhibition, but then re-
enter the cell cycle with limited clonal expansion after
hormonal induction and arrest proliferation, and, finally,
they undergo terminal adipocyte differentiation.
The key transcription factors mediating these pro-
cesses have been identified (Rosen et al., 2000). Upon
activation by either fatty acid derivatives or antidiabetic
thiazolidinediones, PPARg drives the expression of sev-
eral adipocyte-specific genes (Tontonoz et al., 1994a),
and ectopic expression of PPARg induces adipocyte
differentiation (Tontonoz et al., 1994b). Consistent with
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3 Lab address: http://rtcweb.rtc.riken.jp/lab/mg/en/mg.htmlthese observations, PPARg-deficient mice lack white
adipose tissue (Kubota et al., 1999; Rosen et al., 1999).
Mouse embryonic fibroblasts (MEF) lacking both
C/EBPb and C/EBPd failed to express PPARg and
C/EBPa and were unable to undergo adipocyte differen-
tiation (Tanaka et al., 1997). MEFs lacking C/EBPa failed
to express PPARg and were also unable to differentiate
into adipocytes (Wang et al., 1995). Transcription factors
such as E2Fs and STATs have been shown to regulate
the cell cycle during the clonal expansion phase of adi-
pogenesis (Fajas et al., 2002). Further, members of the
forkhead (FOX) family of transcription factors were iden-
tified as playing both positive and negative roles in adi-
pocyte differentiation (Nakae et al., 2003).
A variety of hormones and growth factors are involved
in adipocyte differentiation (Rosen and Spiegelman,
2000), but the precise interplay of these factors is not
fully understood. Bone morphogenetic protein (BMP)
is a member of the transforming growth factor-b (TGF-
b) superfamily. Adipocytes and osteoblasts originate
from common precursor cells (Prockop, 1997). BMP-2
was shown to inhibit adipogenic differentiation but to
stimulate osteogenic differentiation (Gimble et al.,
1995), suggesting that PPARg and BMPs would oppose
each other with respect to cell differentiation. However,
further analyses demonstrated that BMP-2 is a strong
inducer of adipogenic differentiation of 3T3-L1 cells, if
a PPARg ligand is present (Sottile and Seuwen, 2000).
BMP-2 induces expression of PPARg along with adipo-
genesis of C3H10T1/2 cells (Hata et al., 2003). Thus, the
role of BMP in adipocyte differentiation in vitro was
demonstrated, but the role of BMP in adipogenesis
in vivo remains unknown.
Members of the Smad group of proteins are transcrip-
tional activators and mediate BMP/TGF-b/activin sig-
naling (Shi and Massague´, 2003). BMP first binds di-
rectly to the BMP type II receptor, which leads to the
formation of an oligomeric complex of type I and type
II receptors (Heldin et al., 1997). The activated BMP
type I receptor phosphorylates and activates Smad1
and Smad5, which subsequently associate with Smad4,
a common partner for receptor-regulated Smads. Het-
ero-oligomers of Smads move into the nucleus and di-
rectly activate transcription via interactions with the
transcriptional coactivator CBP/p300 (Liu et al., 1996;
Janknecht et al., 1998). Smads 3 and 4 bind directly to
the DNA sequences CAGAC or AGAC (Shi et al., 1998).
In contrast, Drosophila Mad and mammalian Smad1
bind to GC-rich elements (Kim et al., 1997; Kusanagi
et al., 2000).
Drosophila Schnurri (Shn), which is a large protein
containing two separate zinc finger domains, is required
for signaling through Decapentaplegic (Dpp), the Dro-
sophila homolog of BMP (Arora et al., 1995; Grieder
et al., 1995). Vertebrate homologs of Shn were originally
identified as proteins that bind to the NF-kB site of var-
ious genes (Maekawa et al., 1989). Shn forms a complex
with Mad/Medea, the Drosophila homologs of Smad1
and Smad4, respectively, on the silencer element of
the brinker (brk) gene and mediates Dpp-dependent
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462Figure 1. Reduced Adiposity in Shn-22/2
Mice
(A) Epididymal WAT of adult mice. Peritoneal
cavity (left) and epididymal fat pad (right) of 9-
week-old wild-type and Shn-22/2 mice are
shown. Ep, epididymal fat pad; T, testis.
(B) Reduced body weight and epididymal
WAT weight in Shn-22/2 mice. Body weight
(left), epididymal WAT weight/body weight
(middle), and BAT weight/body weight (right)
of 9-week-old wild-type and Shn-22/2 mice
are shown. Each bar represents the mean 6
SEM (n = 5–10). *p < 0.05. N.S., no significant
difference.
(C) Histology of adipose tissue. Sections from
epididymal fat pads were stained with hema-
toxylin and eosin.
(D) Plasma glucose levels during the glucose
tolerance test. Each bar represents the
mean6 SEM (n = 4). ***p < 0.0001; **p < 0.004.
(E) Plasma glucose levels during the insulin
tolerance test. Each bar represents the
mean 6 SEM (n = 4). *p < 0.05.
(F) Plasma insulin levels during the glucose
tolerance test. Each bar represents the
mean 6 SEM (n = 4). There is no significant
difference between wild-type and Shn-22/2
mice.brk gene silencing (Mu¨ller et al., 2003; Pyrowolakis et al.,
2004). Shn is also required for Dpp-induced transcrip-
tional activation of some genes, including spalt, opto-
motor blind, vestigial, and Dad (Torres-Vazquez et al.,
2000). In addition to a direct interaction between Shn
and Mad (Udagawa et al., 2000), Shn was also shown
to bind to the Dpp-responsive enhancer element of the
Ultrabithorax (Ubx) gene (Dai et al., 2000). Thus, Shn is
involved in Dpp-induced transcriptional repression and
activation of multiple target genes. Among three verte-
brate orthologs of Shn (Shn-1, -2, and -3), Shn-2 is re-
quired for T cell development (Takagi et al., 2001; Kimura
et al., 2005), while Shn-3 plays an important role in IL-2
production and the TNF signaling pathway (Oukka
et al., 2002, 2004). However, it is not known whether
mammalian Shn plays a role in BMP/TGF-b/activin sig-
naling. Here, we report that Shn-22/2 mice exhibit re-
duced adiposity. Our results indicate that Shn-2 has
a critical role in BMP-dependent adipogenesis.Results
Reduced Adiposity in Shn-22/2 Mice
Shn-22/2 mice are slightly smaller than wild-type mice
postnatally, and by 9 weeks of age are w20% smaller
in body weight (Figure 1B, left). The fat mass in Shn-
22/2 mice was markedly reduced compared to wild-
type mice (Figure 1A). All the data presented in this study
were obtained from male mice, but the reduced fat mass
was also observed in female Shn-22/2 mice (data not
shown). Epididymal white adipose tissue (WAT) weight
per body weight of Shn-22/2 mice was reduced by
50% compared to wild-type mice (Figure 1B, middle).
Other tissues, including liver, heart, and kidney, had
weights similar to wild-type and no gross abnormalities
(data not shown). There was also no significant differ-
ence in brown adipose tissue (BAT) between Shn-22/2
and wild-type mice (Figure 1B, right). Sections of epidid-
ymal fat fromShn-22/2mice exhibited marked reduction
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463Figure 2. Defects in In Vitro Adipocyte Differ-
entiation of Shn-22/2 MEFs
(A and B) Adipocyte differentiation assay.
MEFs from wild-type and Shn-22/2 mice
were induced to differentiate using differenti-
ation medium containing BMP and PPARg
agonist BRL 49653 (A) or conventional me-
dium (B) which contains insulin and IBMX
but lacks BMP-2. Oil red O staining shows
fat accumulation in cells at 8 days postinduc-
tion.
(C) Shn-2 expression during adipocyte differ-
entiation. Shn-2 mRNA levels during adipo-
cyte differentiation of wild-type MEFs were
measured using real-time RT-PCR. The
mRNA levels (mean 6 SD, n = 3) are shown
relative to preinduction levels. In some cases,
the SD was small and not visible on the plot.in size, with some adipocytes showing a preadipocyte-
like phenotype (Figure 1C). These data suggest that the
reduced WAT mass in Shn-22/2 mice was not due to re-
duced adipocyte number, but inhibition of triglyceride
accumulation in the WAT.
Adipose tissue is now recognized to be an endocrine
organ, and proteins secreted by adipocytes may con-
tribute to organismal insulin sensitivity (Ahima and Flier,
2000). Thus, the decrease in adiposity in Shn-22/2 mice
could affect insulin sensitivity, and, in fact, Shn-22/2
mice showed increased glucose tolerance (Figure 1D)
and a greater glucose-lowering effect of insulin than
wild-type mice (Figure 1E). The plasma insulin levels
during a glucose tolerance test of Shn-22/2mice tended
to be higher than those of wild-type mice (Figure 1F),
raising the possibility that insulin secretion may be in-
creased in Shn-22/2 mice. The increased insulin sensi-
tivity of Shn-22/2 mice, despite lipodystrophy, is similar
to Cbp heterozygous mice (Yamauchi et al., 2002).
Shn-2 Positively Regulates Adipocyte Differentiation
of MEFs
To clarify the mechanism leading to decreased WAT
mass in Shn-22/2 mice, we studied the ability of MEFs
to differentiate into adipocytes. As reported previously
(Sottile and Seuwen, 2000; Hata et al., 2003), BMP-2
strongly stimulates in vitro adipogenesis in the presence
of a PPARg agonist, BRL 49653, but Shn-22/2MEFs had
significantly lower adipocyte differentiation than wild-
type cells (Figure 2A). Although Shn-22/2 MEFs had sig-
nificantly lower adipocyte differentiation than wild-type
cells even in the absence of BMP-2, this could be due
to the presence of small amounts of BMP derived from
serum or produced by MEFs. We also examined whether
Shn-2 affects adipocyte differentiation in the conven-
tional differentiation medium lacking BMP-2. In the pres-
ence of BRL 49653, Shn-22/2 MEFs had significantly
lower adipocyte differentiation than wild-type cells, but
in the absence of BRL 49653, both wild-type andShn-22/2 cells exhibited only low levels of adipocyte dif-
ferentiation (Figure 2B).
To further examine the role of Shn-2 during in vitro ad-
ipocyte differentiation, we examined Shn-2mRNA levels
during differentiation. Immediately after induction of dif-
ferentiation in wild-type MEFs, the Shn-2 mRNA level
decreased to 15% of the level in unstimulated cells,
and then transiently increased to about half the original
level 2 days after induction (Figure 2C). The increase in
Shn-2 mRNA between 6 hr and 2 days postinduction
suggests a role for Shn-2 during this period.
Reduced Levels of PPARg2 mRNA in Shn-22/2 Cells
We then measured mRNA levels of PPARg2 and C/EBP
family members at various times (Figures 3A–3D). Within
1 day postinduction of differentiation, both PPARg2 and
C/EBPa expression was detected, and their expression
continued to increase through day 4 in wild-type cells.
In Shn-22/2 cells, PPARg2 was not induced during 2
days postinduction of differentiation and its level was
about two-thirds that of wild-type cells on day 4. The
C/EBPamRNA level inShn-22/2cells was approximately
one-half and one-quarter that of wild-type cells on days 1
and 2, respectively. C/EBPb and C/EBPd were induced
transiently on day 2 postinduction in wild-type cells,
but not in mutant cells. Thus, expression of all four key
transcription factors was significantly reduced in
Shn-22/2 cells compared to wild-type cells. C/EBPb
andC/EBPdexpression are upregulated prior toPPARg2
and C/EBPa expression in a differentiation system lack-
ing a PPARg agonist and BMP-2 (Rosen et al., 2000). Us-
ing the system containing a PPARg agonist and BMP-2,
PPARg2 andC/EBPa expression begins prior toC/EBPb
and C/EBPd expression (Figures 3A–3D). In addition,
PPARg mutant mice cannot develop adipocytes and ex-
press C/EBPa very poorly (Kubota et al., 1999; Rosen
et al., 1999).C/EBPamutant mice also have dramatically
reduced fat accumulation in WAT pads (Wang et al.,
1995). In contrast, mice lacking C/EBPb or C/EBPd
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464Figure 3. Reduced Levels of PPARg2 and
C/EBPa mRNA in Shn-22/2 MEFs
(A–D) Expression levels of key transcription
factors for adipocyte differentiation. The
levels of PPARg2 (A), C/EBPa (B), C/EBPb
(C), and C/EBPd (D) mRNA during adipocyte
differentiation of wild-type and Shn-22/2
MEFs were measured by real-time RT-PCR.
The levels (mean6 SD, n = 3) are shown rela-
tive to preinduction levels of wild-type MEFs.
In some cases, SD is small and not visible on
the plot.
(E) PPARg2 restores adipogenesis in Shn-22/
2 cells, but C/EBPa does not. Dishes contain-
ing wild-type or Shn-22/2 cells were infected
with a retrovirus expressing PPARg2,
C/EBPa, or vector only. Cells were induced
to differentiate, and stained with Oil red O
after 7 days.
(F) Expression of E2F1, E2F4, and STAT3 dur-
ing adipocyte differentiation of MEFs. Wild-
type and Shn-22/2MEFs were induced to dif-
ferentiate as described in Figure 2A, and
whole-cell lysates were prepared at various
times. Equal amounts of protein per lane
were loaded for SDS-PAGE, followed by
Western blotting to detect the indicated pro-
teins (left).have normal WAT (Tanaka et al., 1997). These results
suggest that reduced fat accumulation in Shn-22/2
mice may be due to diminished expression of PPARg2.
We next examined whether adipocyte differentiation
in Shn-22/2 cells is specifically blocked by reduced
PPARg2 expression by infecting them with a PPARg2-
expressing retrovirus. Ectopic expression of PPARg2
in Shn-22/2 cells resulted in a dramatic increase in adi-
pogenic potential (Figure 3E). As a negative control,
we also overexpressed C/EBPa in Shn-22/2 cells.
C/EBPa failed to induce adipocyte differentiation in
Shn-22/2 MEFs. These data support the hypothesis
that reduced fat accumulation in Shn-22/2 mice is due
to diminished expression of PPARg2.
We also examined the expression of other transcrip-
tion factors during clonal expansion (Figure 3F). As re-
ported previously (Fajas et al., 2002), the levels of E2F1
increased transiently 1 day postinduction in both wild-
type and Shn-22/2 cells. E2F4 was upregulated 1 day
postinduction, and its levels remained elevated for at
least 5 days postinduction in both wild-type and
Shn-22/2 cells. The levels of STAT3 also increased dur-
ing adipocyte differentiation, as reported (Stephens
et al., 1996), in both wild-type and Shn-22/2 cells.
Thus, loss of Shn-2 does not affect the expression oftranscription factors such as E2F1/4 and STAT3, which
control the cell cycle during clonal expansion.
Synergistic Activation of thePPARg2Gene Promoter
by Shn-2, BMP Signaling, and C/EBPa
BMP-2 induces PPARg expression and adipogenesis in
C3H10T1/2 cells (Hata et al., 2003). We analyzed the
effects of BMP-2 on PPARg2 promoter activity using
a PPARg2 promoter-driven luciferase gene (Zhu et al.,
1995). Wild-type MEFs were transfected with the
PPARg2-Luc reporter, and adipocyte differentiation
was induced in the presence or absence of BMP-2.
The luciferase levels of wild-type cells increased 73%
in the presence of BMP-2, whereas the luciferase levels
of Shn-22/2 cells were not affected by BMP-2 treatment
(Figure 4A). Thus, the PPARg2 promoter is weakly re-
sponsive to BMP-2, and Shn-2 is required for this BMP
responsiveness. The low degree of induction by BMP-
2 could be due to an imbalance among the transcription
factors and the promoter molecule in transfected cells.
To further examine the BMP responsiveness of the
PPARg2 promoter and the role of Shn-2, we performed
luciferase reporter assays using wild-type MEFs trans-
fected with thePPARg2-Luc reporter and various combi-
nations of expression plasmids for Smad1/4 and Shn-2
Shn-2 Regulates Adipocyte Differentiation
465Figure 4. Shn-2, BMP Signaling, and C/EBPa
Act Synergistically to Activate the PPARg2
Promoter
(A) BMP responsiveness of the PPARg2 pro-
moter. Wild-type or Shn-22/2 MEFs were
transfected with the PPARg2 promoter-lucif-
erase reporter and treated with BMP-2 or
control solvent. The relative luciferase activ-
ity (mean 6 SD, n = 3) is indicated.
(B) Effect of Shn-2 on PPARg2 promoter ac-
tivity. Wild-type or Shn-22/2 MEFs were
transfected with the PPARg2 promoter-lucif-
erase reporter and vectors to express
Smad1/4, Shn-2, and/or C/EBPa, and treated
with BMP-2 or control solvent. Lower: the rel-
ative luciferase activity is shown (mean6 SD,
n = 3). In most cases, SD is small and cannot
be shown. Upper: the degree of activation by
BMP-2 is shown.
(C) Presence of Smad binding sites in the
PPARg2 promoter region. Six Smad binding
sites in the mouse and human PPARg2 pro-
moters are indicated. Four sites are con-
served between mouse and human.
(D) Synergistic activation requires three
Smad binding sites in the PPARg2 promoter.
The PPARg2 promoter constructs, with six
Smad binding sites (circles) and one putative
Shn-2 binding site (square), are shown sche-
matically. Luciferase reporter assays were
performed as in (A) using the mutant pro-
moter constructs shown in (B), except that
the expression vector for constitutively active
form of BMP receptor (ALK3QD) was cotrans-
fected instead of BMP-2 treatment. The re-
sults are shown in the bar graph at the right.
The luciferase levels (mean 6 SD, n = 3) are
shown relative to the wild-type promoter.(Figure 4B, left). The PPARg2 promoter contains C/EBP
binding sites and its activity is enhanced by C/EBPa
and C/EBPd (Elberg et al., 2000), and, therefore, the
C/EBPa expression plasmid was also used. Without
Smad1/4 or C/EBPa, the BMP-2-induced expression of
luciferase was not observed, whereas BMP-2 enhanced
luciferase expression about 2-fold in the presence of
Smad1/4 and C/EBPa. When Smad1/4, C/EBPa, and
Shn-2 were coexpressed together, higher BMP-2 re-
sponsiveness (3.6-fold) was observed. These results
may support the speculation that the appropriate bal-
ance of these factors and the PPARg2 promoter mole-
cule is needed for BMP responsiveness. When we used
Shn-22/2 MEFs for similar experiments, BMP-2 en-
hanced luciferase expression only about 50% in the
presence of Smad1/4 and C/EBPa (Figure 4B, right).
Exogenous expression of Shn-2 in the mutant cells sig-
nificantly restored the BMP-2 responsiveness of the
PPARg2 promoter (4.5-fold). These results suggest thatShn-2, Smad1/4, and C/EBPa synergistically mediate
the BMP-induced transactivation of the PPARg2 pro-
moter.
Smad3/4 bind to the 50-AGAC-30 sequence (Shi et al.,
1998), while Smad1 binds to GC-rich sequences (Kusa-
nagi et al., 2000). The mouse and human PPARg2 pro-
moter regions contain six AGAC sequences (Figure 4C)
but not the GC-rich sequence. The AGAC sequence
was also found at ten sites in the 1.2 kb promoter region
of the mouse PPARg1 gene (data not shown). Among
these six putative Smad binding sites in the mouse
PPARg2 promoter, four sites (sites 1, 2, 4, and 6) are
conserved in the human PPARg2 promoter (Figure 4C).
We constructed mutant mouse PPARg2-Luc reporters
in which the AGAC sites were mutated, and examined
the level of activation of the reporters by Shn-2,
Smad1/4, ALK3QD, and C/EBPa. The results indicate
that three sites in the upstream region of the promoter
(sites 1–3) are required for synergistic activation by
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466Figure 5. Two Regions of Shn-2 Bind to
Smad1
(A) Shn-2 does not directly bind to the
PPARg2 promoter. 293T cells were trans-
fected with the FLAG-Shn-2 expression plas-
mid, and the cell lysates were immunoprecip-
itated with anti-FLAG antibody. FLAG-Shn-2
was eluted from the immunocomplex by
FLAG peptide, and mixed with the 32P-
labeled DNA fragment containing thePPARg2
promoter. Mixtures were immunoprecipi-
tated with anti-Shn-2 antibody, and the
[32P]-DNA fragment in the immunocomplex
was analyzed by agarose gel.
(B) Coimmunoprecipitation of exogenously
expressed Shn-2 and Smad1/4. The FLAG-
Shn-2 expression plasmid was cotransfected
into 293T cells with plasmids to express the
proteins shown above the panel. Lysates pre-
pared from the cells were immunoprecipi-
tated with anti-FLAG antibodies and ana-
lyzed by Western blotting to detect protein
shown on the left. An aliquot of lysates was
directly used for Western blotting (Input).
(C) Coimmunoprecipitation of endogenous
proteins. Adipocyte differentiation of wild-
type MEFs was induced by exposing the cells
to differentiation medium with or without
BMP-2. Cells were treated additionally with
BMP-2 or control solvent for 15 min at 48 hr
postinduction and lysed in hyptonic buffer,
and the cytosol and nuclear fractions were
separated. Proteins of both fractions were
immunoprecipitated with anti-Shn-2 anti-
body or control IgG, and subjected to West-
ern blotting to detect the proteins shown on
the right. An aliquot of lysates was directly
used for Western blotting (Input).
(D) Identification of the regions of Shn-2
which bind to Smad1. The Shn-2 mutants
used in the GST pull-down assays and a sum-
mary of the results in Figure S2 is indicated on
the right.these factors (Figure 4D). Mutation of any of these
three sites significantly reduced activation by Shn-2,
Smad1/4, ALK3QD, and C/EBPa. The human PPARg2
promoter lacks site 3 but has another Smad site further
upstream of site 1. The presence of three Smad sites in
this region of the mouse and human PPARg2 promoters
may support formation of a Smad1/4-Shn-2-C/EBPa
complex to synergistically activate transcription.
Vertebrate Shn was originally identified as NF-kB site
binding proteins (Maekawa et al., 1989), and the metal
finger regions ofDrosophila and Xenopus Shn recognize
these specific DNA sequences (Mu¨ller et al., 2003; Durr
et al., 2004). No NF-kB recognition sequence was found
in the PPARg2 promoter, but one sequence (50-TCCCAC
CTCTCCC-30) at294 to282 partially resembles theXen-
opus Shn binding sequence. However, mutation of this
site did not affect the synergistic activation of the
PPARg2 promoter by Shn-2, Smad1/4, ALK3QD, and
C/EBPa (Figure 4D).
Direct Interaction between Shn-2 and Smad1/4
To examine whether Shn-2 directly binds to the PPARg2
promoter, a DNA precipitation assay was performed
(Figure 5A). FLAG-Shn-2 was expressed in 293T cells,immunoprecipitated by anti-FLAG antibody, and eluted
from the immunocomplex using FLAG peptide. The pu-
rified Shn-2 protein was mixed with 32P-labeledPPARg2
promoter fragments and precipitated with anti-Shn-2
antibody. The PPARg2 promoter fragment was not de-
tected in the immunocomplex. These results suggest
that Shn-2 does not directly bind and is recruited by
Smad proteins to the PPARg2 promoter.
To investigate the interaction between Shn-2 and
Smad1/4, coimmunoprecipitation assays of the exoge-
nously expressed proteins were performed. 293T cells
were cotransfected with plasmids to express FLAG-
Shn-2, Myc-Smad1, and HA-Smad4, and lysates from
transfected cells were immunoprecipitated with an
anti-FLAG antibody. Myc-Smad1 and HA-Smad4 were
coprecipitated with FLAG-Shn-2 (Figure 5B). When
HA-Smad4 was deleted from this combination, FLAG-
Shn-2 coprecipitated lesser amounts of Myc-Smad1.
When Myc-Smad1 was deleted, HA-Smad4 was not co-
precipitated with FLAG-Shn-2. These results suggest
that Shn-2 interacts with the hetero-oligomers of
Smad1 and Smad4.
Next, we performed coimmunoprecipitation assays
using endogenous proteins of MEFs. MEFs during
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control solvent, and the cytosol and nuclear fractions
were separated. The results of Western blotting indicate
that most of the Smad1, Smad4, and Shn-2 proteins en-
ter into the nucleus upon BMP-2 stimulation (Figure 5C).
Anti-Shn-2 antibody coprecipitated not only the nuclear
Smad1/4 protein in BMP-treated cells but also the cyto-
plasmic Smad1/4 proteins in BMP-untreated cells.
These results suggest that Shn-2 forms a complex
with Smad1/4 in the cytosol, which enters into the nu-
cleus upon BMP-2 stimulation. We also examined the in-
teraction between endogenous Shn-2 and C/EBPa. In
BMP-2-untreated MEFs, about half of the C/EBPa pro-
teins are localized in the cytosol and nucleus each.
Upon BMP-2 stimulation, cytosolic C/EBPa entered
into the nucleus. Anti-Shn-2 antibody coprecipitated
neither cytosolic nor nuclear C/EBPa prepared from
BMP-2-untreated cells. However, nuclear C/EBPa in
BMP-2-treated cells was efficiently coprecipitated by
anti-Shn-2 antibody. Thus, Shn-2 also interacts with
C/EBPa upon BMP-2 stimulation.
To determine which region of Shn-2 protein is respon-
sible for interaction with Smad1, GST pull-down assays
were performed. Two in vitro-translated Shn-2 frag-
ments containing either the N- or C-terminal metal fin-
gers (N1 and C1) bound to a GST-Smad1 resin, whereas
the two fragments containing the central region of Shn-2
(HS and CP) exhibited only background and minor bind-
ing, respectively (Figure 5D). Deletion of the metal finger
regions from N1 and C1 abrogated the interaction with
Smad1, suggesting that both metal finger regions are
important for interactions with Smad1.
Recruitment of Shn-2 to the PPARg2 Promoter
by Smad1/4
To examine whether Shn-2 interacts with Smad1/4
bound to the PPARg2 promoter, we performed gel mo-
bility shift assays. When GST-Smad1 or GST-Smad4
was mixed with a 32P-labeled DNA probe containing
Smad sites 1–3, GST-Smad4 bound to the probe, but
GST-Smad1 did not (Figure 6A, lanes 2 and 3). When
a mixture of GST-Smad1 and GST-Smad4 was incu-
bated with the probe, protein-DNA complexes, which
were supershifted either by anti-Smad1 or anti-Smad4
antibodies, were generated (Figure 6A, lanes 5 and 6).
These results suggest that Smad4 alone or Smad1/4
hetero-oligomers bind to this DNA probe. The results
of the GST pull-down assays described above suggest
that two metal finger regions are critical for binding to
Shn-2. Therefore, we examined whether GST fusion pro-
teins containing these metal finger regions affected the
binding of Smad1/4 oligomers to the DNA probe. Addi-
tion of GST-CMF or GST-NMF, which contain the C- or
N-proximal metal finger region, enhanced Smad1/4-
DNA binding, suggesting that the metal finger regions
of Shn-2 stabilize the Smad1/4-DNA complex (Figure 6A,
lanes 8 and 9). However, we did not observe clear super-
shifted bands containing Shn-2. This could be due to the
low affinity of GST-metal finger protein to Smad1/4.
We then investigated whether Shn-2 is recruited to the
PPARg2 promoter via Smad1/4 in response to BMP
stimulation (Figure 6B). Whole-cell lysates were pre-
pared from 293T cells cotransfected with plasmids
to express FLAG-Shn-2, Myc-Smad1, HA-Smad4,ALK3QD, and C/EBPa. Lysates were mixed with 32P-
labeled PPARg2 promoter fragments and precipitated
with anti-FLAG (Shn-2) or anti-Myc (Smad1) antibodies.
The wild-type PPARg2 promoter fragment was precipi-
tated by these antibodies, but not by control IgG. The
mutant promoter fragment, in which Smad binding sites
1–3 were mutated, was not precipitated with anti-FLAG
(Shn-2) or anti-Myc (Smad1). Although this mutant frag-
ment still retained Smad sites 4–6, Smad binding affinity
for these sites may be much weaker than that for Smad
sites 1–3. When cell lysates were prepared from cells co-
transfected with plasmids to express only four of the five
proteins (lacking Smad4, ALK3QD, or C/EBPa), the wild-
type PPARg2 promoter fragment was not precipitated
with anti-FLAG (Shn-2) or anti-Myc (Smad1). We
performed a two-step immunoprecipitation in which
anti-FLAG (Shn-2) or anti-Myc (Smad1) was used for
the first immunoprecipitation, and the immunocomplex
was eluted with DTT, followed by a second immunopre-
cipitation with the other antibody. The wild-type
PPARg2 promoter fragment was precipitated, although
the efficiency was low. These results suggest that Shn-2
interacts with the PPARg2 promoter via Smad1/4 bound
to Smad sites 1–3 and C-EBPa.
Using chromatin immunoprecipitation (ChIP) assays,
we examined whether Smad1 and Shn-2 bind to the
PPARg2 gene promoter in response to BMP-2 treat-
ment. The amounts of Smad site-containing promoter
DNA fragment precipitated with anti-Smad1 or anti-
Shn-2 antibodies increased following BMP-2 treatment
of wild-type cells (Figure 6C). However, this increase in
the amount of Smad1-bound DNA was not observed in
Shn-22/2 cells. The adjacent DNA fragment which is lo-
cated further upstream was not precipitated by either
anti-Smad1 or anti-Shn-2 antibodies (see Figure S1A in
the Supplemental Data available with this article online).
The control ChIP experiments using anti-acetylated his-
tone H4 indicated that the chromatin was adequately
prepared from Shn-22/2 cells (Figure S1B). To examine
whether Smad1 is required for Shn-2 binding to the
PPARg2 promoter, we decreased the levels of Smad1
protein using siRNAs. The levels of Smad1 proteins in
cells transfected with Smad1 siRNAs were about
20% of that in cells transfected with GFP siRNA as a
control (Figure 6D). The BMP-2-dependent increase in
the Shn-2-bound DNA was not observed in cells trans-
fected with Smad1 siRNAs. These results indicate that
Smad1 is required for binding of Shn-2 to the PPARg2
promoter.
BMP-2 Induces Nuclear Entry of Shn-2
The subcellular localization of the endogenous Shn-2
protein in MEFs during adipocyte differentiation was ex-
amined. In the absence of BMP-2 stimulation, Shn-2 was
primarily in the cytoplasm, although some signal was
detected in the nucleus (Figure 7A). Fifteen minutes after
BMP-2 stimulation, Shn-2 became concentrated in the
nucleus. Smad1 was distributed in both the cytosol
and nucleus in the absence of BMP-2 treatment, but ac-
cumulated in the nucleus following BMP-2 treatment.
Thus, BMP-2 induced the nuclear entry of both Shn-2
and Smad1. PPARg2 was not detected in BMP-2-un-
treated cells (Figure 7B), but in cells treated with BMP-2,
PPARg2 signals were detected in cells in which Shn-2
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Promoter via Smad1
(A) Gel mobility shift assays. GST-Smad1,
GST-Smad4, GST, or a mixture was incu-
bated with a DNA probe containing Smad
binding sites 1–3 of the PPARg2 promoter,
and separated by gel electrophoresis fol-
lowed by autoradiography. In some lanes,
anti-Smad1 or anti-Smad4 antibody, GST-
CMF, or GST-NMF were added. GST-CMF
and GST-NMF contain the C- and N-proximal
metal finger regions, respectively. In the right
panel, GST fusion proteins were analyzed by
SDS-PAGE, followed by Coomassie blue
staining.
(B) Shn-2 is recruited to the PPARg2 pro-
moter via the Smad sites. DNA fragments
containing the wild-type or mutant (in which
Smad binding sites 1–3 are mutated)PPARg2
promoter were 32P labeled, and mixed with
cell lysates from 293T cells transfected with
a mixture of five plasmids to express FLAG-
Shn-2, Myc-Smad1, HA-Smad4, ALK3QD,
and C/EBPa (All). Lysates were immunopre-
cipitated with the antibodies indicated above,
and the [32P]-DNA fragment in the immuno-
complex was analyzed by agarose gel. In
some cases, lysates were prepared from the
cell transfected with a mixture of four of the
five plasmids; the missing plasmid is indi-
cated below each panel. For two-step immu-
noprecipitation, anti-FLAG (Shn-2) was first
used for immunoprecipitation, and then
anti-Myc (Smad1) was used for the second
immunoprecipitation. The order of antibodies
was reversed in parallel assays.
(C) ChIP assays. MEFs from wild-type and
Shn-22/2 mice were induced to differentiate
with or without BMP-2, as described in
Figure 2A. Soluble chromatin was prepared,
and immunoprecipitated with anti-Smad1
(left) or anti-Shn-2 (right), or control IgG. The
final DNA extraction was amplified by real-
time PCR using primers that cover the
PPARg2 promoter region containing Smad
binding sites 1–3. The relative densities of
bands are indicated. To decrease the levels
of Smad1, MEFs were transfected with Smad1 siRNA or GFP siRNA as a negative control, and then induced to differentiate with or without
BMP-2. ChIP assays were performed as above. Each bar represents the mean 6 SEM (n = 3).
(D) A decrease in the Smad1 levels by siRNA. MEFs were transfected with Smad1 siRNA or GFP siRNA, and cell lysates were prepared and then
used for Western blotting with anti-Smad1 antibody.had entered the nucleus (Figure 7B, arrow 1 and photo
1). Some BMP-2-treated cells still retained Shn-2 in the
cytoplasm, and in these cells PPARg2 expression was
not detected (Figure 7B, arrowhead 2 and photo 2).
Discussion
The present study demonstrates that Shn-2 enters the
nucleus upon BMP stimulation and plays an important
role in adipocyte differentiation. The role of BMP in adi-
pocyte differentiation was previously suggested using
an in vitro system, but our current study strongly sug-
gests that BMP has a critical role in vivo. Upon BMP
stimulation, Shn-2 is recruited to the PPARg2 promoter
via an interaction with Smad1 (Figure 7C). This is, to our
knowledge, the first demonstration that Shn plays a role
in vertebrate BMP/TGF-b/activin signaling. Shn-2 is re-
quired for efficient transcription of PPARg2, possiblyas a scaffold protein to form a ternary complex with
Smad1/4 and C/EBPa. Interestingly, Evi-1, which is
also a large protein containing two regions of metal fin-
gers like Shn-2, interacts with and represses TGF-b/
BMP-activated transcription through Smad proteins (Al-
liston et al., 2005). Following TGF-b stimulation, Evi-1
and the associated corepressor CtBP are recruited to
the target promoter. Thus, Shn-2 and Evi-1 interact
with Smad proteins via their metal fingers and may stim-
ulate and repress transcription by recruiting coactivator
and corepressor, respectively.
Although vertebrate Shn proteins were originally iden-
tified as the NF-kB site binding proteins (Maekawa et al.,
1989), our present study indicates that Shn-2 is recruited
to the PPARg2 promoter via an interaction with Smad1
and C/EBPa. This is similar to the recent report that
Drosophila Shn forms a complex with Mad/Medea on
the silencer element of the brinker (brk) gene to mediate
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Shn-2
(A) Nuclear entry of Shn-2 upon BMP-2 stim-
ulation. Adipocyte differentiation of wild-type
MEFs was induced by exposing the cells to
differentiation medium with or without BMP-
2. Cells were treated additionally with BMP-
2 or control solvent for 15 min at 48 hr postin-
duction, and were stained with anti-Shn-2,
anti-Smad1, and Hoechst, and visualized
with FITC- and rhodamine-conjugated sec-
ondary antibodies using confocal micros-
copy. The bottom panels show merged im-
ages.
(B) Nuclear entry of Shn-2 induces PPARg2
expression. Adipocyte differentiation of
wild-type MEFs was induced, and cells were
stained with anti-Shn-2, anti-PPARg2, and
TOTO-3 as described above. The Shn-2
staining patterns of some cells are shown at
the right with higher magnification. In the
cell indicated by arrow 1, Shn-2 is localized
in the nucleus, and a PPARg2 signal was ob-
served. Arrowheads 2 and 3 show two cells
with Shn-2 localized in the cytoplasm, and
PPARg2 was not detected.
(C) Model for the role of Shn-2 in BMP-depen-
dent PPARg2 induction.Dpp-dependent brk gene silencing (Pyrowolakis et al.,
2004). The brinker silencer element contains three 50-
AGAC-30 sequences and two GC-rich sequences be-
tween them, to which Medea and Mad bind, respec-
tively. However, the GC-rich sequence was not found
between three 50-AGAC-30 sequences in the PPARg2
promoter. Therefore, more work is required to under-
stand whether Smad1 in the Smad1/4 hetero-oligomers
directly recognizes the DNA sequence in the PPARg2
promoter. Interaction of Shn-2 not only with Smad1/4
but also with C/EBPa may support the idea that Shn-2
serves as a scaffold protein to form a ternary complex
with various transcription factors to synergistically
activate transcription (Figure 7C). In fact, Shn-3 was
reported to interact with c-Jun to activate IL-2 gene
transcription (Oukka et al., 2004).
Adipogenesis in vitro follows a highly ordered and
well-characterized temporal sequence. In cultured cell
models, initial growth arrest is induced by the addition
of a prodifferentiative hormonal regimen and is followed
by one or two additional rounds of cell division (clonal
expansion). This process ceases upon induction of
PPARg2 and C/EBPa, which is concomitant with perma-
nent growth arrest followed by expression of the fully
differentiated phenotype. E2F1 induces PPARg2 tran-
scription during clonal expansion, whereas E2F4 re-
presses PPARg2 expression during terminal adipocyte
differentiation (Fajas et al., 2002). Interaction between
Smad and E2F proteins has been shown for the
Smad3-E2F4/5 complex mediating TGF-b-inducedrepression of c-myc (Chen et al., 2002). Therefore,
Smad1/4-Shn-2 may also participate in E2F-dependent
transcriptional regulation of PPARg2 by directly inter-
acting with E2F1/4. IFNg decreases the expression of
PPARg2 in preadipocytes (Waite et al., 2001), but the
mechanism remains to be elucidated. IFNg induces the
expression of Smad7, which prevents TGF-b receptor-
mediated Smad3 phosphorylation (Ulloa et al., 1999).
IFNg may suppress PPARg2 transcription by inducing
Smad6, which then prevents BMP receptor-mediated
Smad1 phosphorylation. FoxO1 is also known to regu-
late adipocyte differentiation (Nakae et al., 2003).
FoxO1 is induced in the early stages of adipocyte differ-
entiation, and prevents adipose differentiation by upre-
gulating multiple genes, including cell cycle inhibitors.
Insulin leads to nuclear exclusion of FoxO1 and stimu-
lates adipocyte differentiation. Smad proteins activated
by TGF-b form a complex with FoxO proteins to turn on
the growth-inhibitory gene p21Cip1 (Seoane et al.,
2004), and BMP-7 induces higher p21 expression than
TGF-b1. By interacting with FoxO proteins, therefore,
Smad1/4-Shn-2 may also regulate transcription not
only of PPARg2 but also of p21 during adipocyte differ-
entiation.
Although more work is required to understand the role
of Smad1/4-Shn-2 during adipocyte differentiation,
identification of BMP signaling as the key regulatory
pathway of adipogenesis in vivo may enable the devel-
opment of drugs to affect this signaling pathway to sup-




Shn-22/2 mice have been described previously (Takagi et al., 2001).
Animals used in this study were 9-week-old males. Epididymal fat
was removed and the specimens were fixed in 4% paraformalde-
hyde and embedded in paraffin. Serial sections (10 mm) were
mounted on slides and stained with hematoxylin and eosin.
Glucose and Insulin Tolerance Tests
For glucose tolerance tests, animals were fasted overnight, from
17:00 to 9:00 the next day. Animals were injected intraperitoneally
with a bolus of glucose (1.5 g/kg), and then blood glucose levels
were measured using Glutest PRO R (Sanwa Kagaku). Insulin levels
were measured using a mouse insulin ELISA kit (U-type) (Shibayagi).
For insulin tolerance tests, animals were fasted for 6 hr, from 9:30 to
15:30. Mice were injected intraperitoneally with a 0.75 U/kg of re-
combinant human insulin (Eli Lilly), and blood glucose levels were
measured as described above.
In Vitro Adipogenic Differentiation
MEFs were prepared from 14.5-day-old embryos. Induction of adi-
pogenic differentiation was carried out essentially as described by
Sottile and Seuwen (2000), with minor modifications. MEFs were
seeded at a density of 1.6 3 104 cells per cm2 in six-well plates
and grown to confluence for 3–4 days. Cultures were then treated
with 1 mM BRL 49653, 300 ng/ml BMP-2, 0.1 mM 3-isobutyl-1-meth-
ylxanthine (IBMX), 10 mM b-glycerophosphate, and 50 mM ascorbic
acid phosphate. Cultures were maintained under differentiating con-
ditions for up to 8 days and the medium was changed twice weekly.
Standard differentiation-inducing medium contained 0.5 mM isobu-
tylmethylxanthine (IBMX), 1 mM dexamethazone, 5 mg/ml insulin,
10% fetal bovine serum, and 1 mM BRL 49653. The presence of ma-
ture adipocytes was assessed by Oil red O staining. To examine the
effect of PPARg2 or C/EBPa expression on the adipocyte differenti-
ation of Shn-22/2 cells, cells were infected with the PPARg2 or C/
EBPa retrovirus and exposed to differentiation medium. The
PPARg2 virus vector (Kubota et al., 1999) was kindly provided by
Dr. T. Kitamura. The C/EBPa virus vector was generated using the
pMSCV-IRES-puro vector.
Luciferase Reporter Assays
The DNA fragment containing the mouse PPARg2 promoter (nucle-
otides2615 to +64) was amplified using PCR and cloned into the lu-
ciferase reporter pGL3(R2.2)-basic vector (Promega). To examine
BMP-2 responsiveness of the PPARg2 promoter (Figure 4A), MEFs
were transfected with 5 mg of the PPARg2 promoter-Luc reporter us-
ing LipofectAMINE PLUS (Invitrogen) and cultured until confluent,
and then adipogenesis was induced in the presence or absence of
BMP-2. The cultures were treated additionally with BMP-2 or control
solvent for 2 hr at 48 hr postinduction and the luciferase activity was
measured. To examine synergistic activation of the PPARg2 pro-
moter by Shn-2, Smad1/4, and C/EBPa, MEFs (1.8 3 105 cells per
60 mm dish) were transfected using LipofectAMINE PLUS with a mix-
ture of the PPARg2 promoter-Luc reporter (0.5 mg), the plasmids to
express Smad1/4, Shn-2 (0.5 mg each), or C/EBPa (50 ng), and the
internal control plasmid pRL-TK (0.01 mg). Twenty-four hours after
transfection, cells were treated with BMP-2 (500 ng/ml) or control
solvent, and used for luciferase activity assays. The total amount
of plasmid DNA was adjusted to 3 mg by addition of control plasmid
lacking the protein-coding region. Dual luciferase assays were used
to normalize the luciferase activity. To disrupt the putative Smad and
Shn-2 binding sites in the PPARg2 promoter, 50-AGAC-30 and 50-
TCCCACCTCTCC-30 were mutated into 50-CGCC-30 and 50-
GCCCACCGCGCC-30, respectively.
Subcellular Localization
MEFs were cultured until confluent and then adipogenesis was in-
duced in the presence or absence of BMP-2. The cultures were
treated additionally with BMP-2 or control solvent for 15 min at 48
hr postinduction. Cells were immediately fixed with 2% paraformal-
dehyde, and stained with either rabbit anti-Shn-2, which was raised
against Pseudomonas exotoxin-Shn-2 fusion proteins containing
amino acids 1986–2430 of mouse Shn-2, anti-Smad1 (Santa Cruz,N-18), or anti-PPARg (Santa Cruz, E-8). DNA was stained with
Hoechst 33258 (Dojindo, 0.1 mg/ml) or TOTO-3 (Molecular Probes).
Signals for Shn-2 and Smad1 were visualized using Alexa 488- and
Alexa 546-conjugated secondary antibodies, respectively, and ana-
lyzed by confocal microscopy or deconvolution microscopy.
Other parts of the Experimental Procedures are shown in the Sup-
plemental Data.
Supplemental Data
Supplemental Data include two figures and Experimental Proce-
dures and are available at http://www.developmentalcell.com/cgi/
content/full/10/4/461/DC1/.
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